News Novo sales up, but CEO warns of fresh US price crackdown Certain US states drafting new pricing legislation
Articles MINT: opportunities in 'frontier' markets? The prospects for pharma in the MINT emerging countries of Mexico, Indonesia, Nigeria and Turkey.
News Roche pulls cancer drug from Greece in pricing row Roche has withdrawn a cancer drug from Greece, saying that a series of government-imposed price discounts have made it impossible to market the drug there.
Partner Content Partner Content Intellectual Property and Regulatory Law: Recent Development... Intellectual Property Law
Partner Content Partner Content Attendee list for Biosimilars North America 2017 released Attendee list for Biosimilars North America 2017 releas
Views & Analysis Addressing market access obstacles for rare bleeding disorde... Scrutiniseing the market access situation for people with rare bleeding disorders.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
